Partnership to tackle lack of resources on veterinary AMR
The WSAVA has linked up with the European Network for Optimization of Veterinary Antimicrobial Treatment (ENOVAT) to develop and disseminate evidence-based clinical guidelines for the optimization of antimicrobial treatment in companion animal veterinary medicine.
full
ENOVAT is currently working on two sets of Guidelines:
- A set of Guidelines for canine acute diarrhea
- A set of Guidelines for antimicrobial use in surgical prophylaxis in companion animals.
The WSAVA will:
- Provide feedback from its members to ensure their relevance globally
- Support their translation into a range of languages
- Produce a series of infographics to help reinforce key information points.
Two members of the WSAVA Therapeutics Guidelines Group, Chair Dr Luca Guardabassi and Dr Scott Weese, are contributing to their development. Dr Guardabassi says:
Dr Luca Guardabassi
Co-Chair of the WSAVA TGG
This is a timely collaboration as it is essential to offer veterinarians evidence-based guidelines on rational antimicrobial use in companion animals.
The WSAVA looks forward to playing a key role in disseminating the key recommendations from these documents, making them accessible and understandable to a wide audience of general practitioners on a global scale.
horizontal
The WSAVA’s Therapeutics Guidelines Group is focused on ensuring best practices for the selection and responsible use of medicines in companion animals, while engaging the participation of stakeholders and the WSAVA global community in the concept of One Health. Its work is kindly supported by Zoetis.
full
default
Read the full press release
https://wsava.org/wp-content/uploads/2021/08/ENOVAT-and-WSAVA-Join-Forces-on-Clinical-Guidelines-for-Antimicrobial-Treatment.pdf
icon-megaphone
left
2